Evidence map›Paper›PMID 28360147›Full record

ArticleHaematologica2017

A three-dimensional

Laura J Bray, Marcus Binner, Yvonne Körner, Malte von Bonin, Martin Bornhäuser, Carsten Werner

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. PeerJ · 2024
    Article
  14. Review
  15. Modeling Acute Myeloid Leukemia Using StarPEG-Heparin Hydrogels.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Laura J BrayMax Bergmann Center of Biomaterials, Leibniz Institute of Polymer Research Dresden, Germany Laura.bray@qut.edu.au.
Marcus BinnerMax Bergmann Center of Biomaterials, Leibniz Institute of Polymer Research Dresden, Germany.
Yvonne KörnerMax Bergmann Center of Biomaterials, Leibniz Institute of Polymer Research Dresden, Germany.
Malte von BoninUniversitätsklinikum Carl-Gustav Carus, Faculty of Medicine, Technische Universität Dresden, Saxony, Germany.
Martin BornhäuserUniversitätsklinikum Carl-Gustav Carus, Faculty of Medicine, Technische Universität Dresden, Saxony, Germany.
Carsten WernerMax Bergmann Center of Biomaterials, Leibniz Institute of Polymer Research Dresden, Germany.
Leibniz Institute of Polymer Research · DEDeutschen Konsortium für Translationale Krebsforschung · DEQueensland University of Technology · AUTechnische Universität Dresden · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell CommunicationNeovascularization, PathologicTumor MicroenvironmentBenzylaminesBiomarkersCell Culture TechniquesCell Line, TumorCell MovementCyclamsCytarabineDaunorubicinDrug Resistance, NeoplasmDrug SynergismHeterocyclic CompoundsHumansImmunophenotypingBenzylaminesBiomarkersCyclamsCytarabineDaunorubicinHeterocyclic CompoundsplerixaforReceptors, CXCR4

Identifiers

PMID28360147
PMCPMC5566030
OpenAlexW2598739347

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.